Skip to main content

Advertisement

SpringerLink
Log in

Spontaneously regressive multifocal bone pseudomyogenic hemangioendothelioma in a 17-year-old boy: a case report

  • Case Report
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Pseudomyogenic hemangioendothelioma (PMH) is a rare vascular tumor that occurs in young mostly male patients. Seventy percent of PMH cases are multifocal and 25% involve bones. PMH is an indolent tumor with mild local aggressiveness and an unclear pathology. Only two cases of spontaneous regressive bone PMH have been reported. Here, we report the case of a 17-year-old boy with a multifocal bone PMH diagnosed from a chronic pain in his left knee. The PMH affected the right scapula, both humeri, the right olecranon, the second metacarpal bone, the second and fourth right ribs, the thoracic and lumbar spine, the pelvic ring, the left and right femoral neck, and the left patella. Every lesion presented with a lobulated, lytic pattern, sometimes with a peripheral sclerotic rim. MRI showed a tissue lesion with a low intensity on T1-weighted sequences and high intensity on T2-weighted sequences. Enhancement of T1 gadolinium fat-saturated sequences was bright. After discussion, a national specialized board decided to actively monitor the patient and start general chemotherapy in the case of progression. The disease was stable at 3 and 6 months and showed signs of regression at 1 year, which was further confirmed at 2 years. CT scan and MRI highlighted a progressive filling of the tumor with cancellous bone and a regression of the tissue contingent. This case report highlights to a new therapeutic approach for indolent PMH that does not prevent further treatment in the case of progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Hornick JL, Fletcher CD. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol. 2011;35:190–201.

    Article  Google Scholar 

  2. Fletcher CDM, World Health Organization, International Agency for Research on Cancer. WHO classification of tumors of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.

  3. Walther C, Tayebwa J, Lilljebjörn H, Magnusson L, Nilsson J, von Steyern FV, Øra I, Domanski HA, Fioretos T, Nord KH, Fletcher CD, Mertens F. A novel SERPINE1-FOSB fusion gene results in transcriptional up-regula- tion of FOSB in pseudomyogenic haemangioendothelioma. J Pathol. 2014;232:534–40.

    Article  CAS  Google Scholar 

  4. Trombetta D, Magnusson L, von Steyern FV, et al. Translocation t(7;19)(q22;q13)-a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma? Cancer Genet. 2011;204(4):211–5. https://doi.org/10.1016/j.cancergen.2011.01.002.

    Article  CAS  Google Scholar 

  5. Mirra JM, Kessler S, Bhuta S, Eckhardt J. The fibroma-like variant of epithelioid sarcoma. Cancer. 1992;15:1382–95.

    Article  Google Scholar 

  6. Billings SD, Folpe AL, Weiss SW. Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol. 2003;27:48–57.

    Article  Google Scholar 

  7. Amary MF, O’Donnell P, Berisha F, Tirabosco R, Briggs T, Pollock R, et al. Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases. Skelet Radiol. 2013;42:947–57.

    Article  Google Scholar 

  8. Sheng W, Pan Y, Wang J. Pseudomyogenic hemangioendothelioma: report of an additional case with aggressive clinical course. Am J Der- matopathol. 2013;35:597–600.

    Google Scholar 

  9. Righi A, Gambarotti M, Picci P, Dei Tos AP, Vanel D. Primary pseudomyo- genic haemangioendothelioma of bone: report of two cases. Skelet Radiol. 2014;44:727–31.

    Article  Google Scholar 

  10. Karakasli A, Karaaslan A, Erduran M, Capkin S, Tuna EB, Havitcioglu H. Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma with bone invasion. J Orthop. 2014;11:197–9.

    Article  Google Scholar 

  11. McGinity M, Bartanusz V, Dengler B, Birnbaum L, Henry J. Pseudomyo- genic hemangioendothelioma (epithelioid sarcoma-like hemangioen- dothelioma, fibroma-like variant of epithelioid sarcoma) of the thoracic spine. Eur Spine J. 2013;22:S506–11.

    Article  Google Scholar 

  12. Inyang A, Mertens F, Puls F, Sumathi V, Inwards C, Folpe A, Lee CH, Zhang Y, Symmans P, Rubin B, Nielsen GP, Nguyen VH, Rosenberg AE. Primary Pseudomyogenic Hemangioendothelioma of Bone. Am J Surg Pathol. 2016;40:587–98.

    Article  Google Scholar 

  13. Rekhi B, Ramadwar M. Cytomorphological features of an unusual case of a multifocal pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma in a young adult male. Diagn Cytopathol. 2021;49:E106–12.

    Article  Google Scholar 

  14. Shah AR, Fernando M, Musson R, Kotnis N. An aggressive case of pseudomyogenic haemangioendothelioma of bone with pathological fracture and rapidly progressive pulmonary metastatic disease: case report and review of the literature. Skeletal Radiol. 2015;44:1381–6.

    Article  Google Scholar 

  15. Bryanton M, Makis W. Pseudomyogenic hemangioendothelioma mimicking multiple myeloma on 18F-FDG PET/CT, followed by spontaneous regression. Clin Nucl Med. 2015;40:579–81.

    Article  Google Scholar 

  16. Sun Y, Zhao M, Lao IW, Yu L, Wang J. The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature. Virchows Arch. 2020;477:231–40.

    Article  CAS  Google Scholar 

  17. Joseph J, Wang WL, Patnana M, Ramesh N, Benjamin R, Patel S, Ravi V. Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma. Clin Sarcoma Res. 2015;19(5):22.

    Article  Google Scholar 

  18. Gabor KM, Sapi Z, Tiszlavicz LG, et al. Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma. Pediatr Blood Cancer. 2017;00: e26781.

    Google Scholar 

  19. Ozeki M, Nozawa A, Kanda K, Hori T, Nagano A, Shimada A, et al. Everolimus for treatment of pseudomyogenic hemangioendothelioma. J Pediatr Hematol Oncol. 2017;39:e328–31.

    Article  Google Scholar 

  20. Van IJzendoorn DGP, Sleijfer S, Gelderblom H, Eskens FALM, van Leenders GJLH, Szuhai K, Bovée JVMG. Telatinib is an effective targeted therapy for pseudomyogenichemangioendothelioma. Clin Cancer Res. 2018;1;24:2678-2687.

  21. Garces de Los Fayos Alonso I, Liang HC, Turner SD, Lagger S, Merkel O, Kenner L. The role of activator protein-1 (AP-1) family members in CD30-positive lymphomas. Cancers (Basel). 2018;10:93.

  22. Jia J, Ye T, Cui P, Hua Q, Zeng H, Zhao D. AP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation. Microvasc Res. 2016;105:103–8.

    Article  CAS  Google Scholar 

  23. Otani S, Nakayama R, Sekita T, Hirozane T, Asano N, Nishimoto K, Sasaki A, Okita H, Morioka H, Nakamura M, Matsumoto M. Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report. BMC Cancer. 2019;3(19):872.

    Article  Google Scholar 

  24. Righi A, Sbaraglia M, Gambarotti M, Gibertoni D, Rovira MP, Benini S, Errani C, Brenca M, Maestro R, Dei Tos AP. Primary vascular tumors of bone: a monoinstitutional morphologic and molecular analysis of 427 cases with emphasis on epithelioid variants. Am J Surg Pathol. 2020;44:1192–203.

    Article  Google Scholar 

  25. Hung YP, Fletcher CD, Hornick JL. FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma. Am J Surg Pathol. 2017;41:596–606.

    Article  Google Scholar 

  26. Pradhan D, Schoedel K, McGough RL, Ranganathan S, Rao UNM. Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue- a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study. Hum Pathol. 2018;71:126–34.

    Article  Google Scholar 

  27. Santini-Araujo E, Kalil R, Bertoni F, Park Y-K, editors. Tumors and tumor-like lesions of bone. London: Springer-Verlag; 2015.

    Google Scholar 

  28. Violon F, Burns R, Mihoubi F, et al. Intramedullary, periosteal, and extraskeletal Ewing sarcomas: retrospective study of a series of 126 cases in a reference center. Skeletal Radiol. 2022;51:1659-1670 27.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Pontchaillou University Hospital, 2 rue Henri Le Guilloux, 35033, Rennes, France

    Julien Maximen, Alexis Christory & Mickael Ropars

  2. Department of Pediatric Hematology and Oncology, 2 avenue de Bulgarie, 35000, Rennes, France

    Jacinthe Bonneau-Lagacherie

  3. Department of Medical Imaging, Rennes University Hospital, 2 avenue de Bulgarie, 35000, Rennes, France

    Raphael Guillin

Authors
  1. Julien Maximen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexis Christory
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacinthe Bonneau-Lagacherie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raphael Guillin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mickael Ropars
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julien Maximen.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maximen, J., Christory, A., Bonneau-Lagacherie, J. et al. Spontaneously regressive multifocal bone pseudomyogenic hemangioendothelioma in a 17-year-old boy: a case report. Skeletal Radiol 52, 119–127 (2023). https://doi.org/10.1007/s00256-022-04109-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-022-04109-2

Keywords

Search

Navigation